- Company Information
- Fastest-growing Companies
- Updated:10/29/20
- Country/Territory:U.S.
- Headquarters:Menlo Park, Calif.
- Industry:Pharmaceuticals
- CEO:Joseph Belanoff
- Website:https://www.corcept.com
- Ticker:CORT
- Company type:Public
- Revenues ($M):$335
- Profits ($M):$106
- Market value ($M):$2,028
- Number of employees:206
Revenue and net income for the four quarters ended on or before April 30,2020. Market value as of Sept. 29, 2020
- Revenue 3 Yr Growth Rank:5
- Revenue 3 Yr Annual Growth Rate:53%
- EPS 3 Yr Growth Rank:20
- EPS 3 Yr Annual Growth Rate:80%
- Total Return 3 Yr Rank:56
- Total Return 3 Yr Annual Rate:13%
- Beat S&P 500 3 Yr Return:yes
- Current Streak:2
- Years on List:2
- Sector:Health Care
Corcept Therapeutics stock chart
Corcept Therapeutics in Fortune Rankings
- 100 Fastest-Growing Companies